139 related articles for article (PubMed ID: 1263740)
21. Metabolism of delta-1-tetrahydrocannabinol by the rat in vivo and in vitro.
Siemens AJ; Kalant H
Biochem Pharmacol; 1975 Apr; 24(7):755-62. PubMed ID: 235932
[No Abstract] [Full Text] [Related]
22. Metabolism of delta1-tetrahydrocannabinol by rats tolerant to cannabis.
Siemens AJ; Kalant H
Can J Physiol Pharmacol; 1974 Dec; 52(6):1154-66. PubMed ID: 4451887
[No Abstract] [Full Text] [Related]
23. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
Jones G; Pertwee RG
Br J Pharmacol; 1972 Jun; 45(2):375-7. PubMed ID: 5048656
[TBL] [Abstract][Full Text] [Related]
24. Delta9-tetrahydrocannabinol-uptake by rat liver lysosomes.
Irvin JE; Mellors A
Biochem Pharmacol; 1975 Jan; 24(2):305-7. PubMed ID: 1111544
[No Abstract] [Full Text] [Related]
25. Distribution and metabolism in vivo of 14C-tetrahydrocannabinol in the rat.
Willinsky MD; Kalant H; Meresz O; Endrenyi L; Woo N
Eur J Pharmacol; 1974 Jun; 27(1):106-19. PubMed ID: 4851409
[No Abstract] [Full Text] [Related]
26. 9 -Tetrahydrocannabinol and its metabolites in monkey brains.
Ho BT; Estevez V; Englert LF; McIsaac WM
J Pharm Pharmacol; 1972 May; 24(5):414-6. PubMed ID: 4403817
[No Abstract] [Full Text] [Related]
27. Distribution of radioactivity in brain of tolerant and nontolerant pigeons treated with 3 H- 9 -tetrahydrocannabinol.
Dewey WL; McMillan DE; Harris LS; Turk RF
Biochem Pharmacol; 1973 Feb; 22(3):399-405. PubMed ID: 4687135
[No Abstract] [Full Text] [Related]
28. Comparative autoradiographic and metabolic study of delta8- and delta9-tetrahydrocannabinol in the brain of the marmoset Callithrix jacchus.
Erdmann G; Just WW; Thel S; Werner G; Wiechmann M
Psychopharmacology (Berl); 1976 May; 47(1):53-8. PubMed ID: 822439
[TBL] [Abstract][Full Text] [Related]
29. 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs.
Martin BR; Dewey WL; Harris LS; Beckner JS
J Pharmacol Exp Ther; 1976 Jan; 196(1):128-44. PubMed ID: 1246007
[TBL] [Abstract][Full Text] [Related]
30. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
[No Abstract] [Full Text] [Related]
31. Effects of delta9-tetrahydrocannabinol on neurotransmitter accumulation and release mechanisms in rat forebrain synaptosomes.
Johnson KM; Ho BT; Dewey WL
Life Sci; 1976 Aug; 19(3):347-56. PubMed ID: 957874
[No Abstract] [Full Text] [Related]
32. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
Pryor GT; Husain S; Mitoma C
Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
[No Abstract] [Full Text] [Related]
33. Transformation of delta-1-tetrahydrocannabinol (THC) by rabbit liver microsomes.
Ben-Zvi Z; Burstein S
Biochem Pharmacol; 1975 May; 24(10):1130-1. PubMed ID: 1156437
[No Abstract] [Full Text] [Related]
34. Delta-9-tetrahydrocannabinol action and neuronal membrane-bound enzymes.
Ghosh JJ; Poddar MK; Nag D; Biswas B
Prog Brain Res; 1975; 42():375. PubMed ID: 735
[No Abstract] [Full Text] [Related]
35. Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice.
Lawrence DK; Pertwee RG; Gill EW; Piper JM
Biochem Pharmacol; 1974 Nov; 23(21):3017-27. PubMed ID: 4429599
[No Abstract] [Full Text] [Related]
36. Binding of (+)- and (minus)-delta-1-tetrahydrocannabinols and (minus)-7-hydroxy-delta-1-tetrahydrocannabinol to blood cells and plasma proteins in man.
Widman M; Agurell S; Ehrnebo M; Jones G
J Pharm Pharmacol; 1974 Nov; 26(11):914-6. PubMed ID: 4156569
[No Abstract] [Full Text] [Related]
37. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
Gill EW; Jones G
Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
[No Abstract] [Full Text] [Related]
38. The physiologic disposition of marihuana in man.
Lemberger L; Rubin A
Life Sci; 1975 Dec; 17(11):1637-42. PubMed ID: 1107735
[No Abstract] [Full Text] [Related]
39. Residual Effects of THC via Novel Measures of Brain Perfusion and Metabolism in a Large Group of Chronic Cannabis Users.
Filbey FM; Aslan S; Lu H; Peng SL
Neuropsychopharmacology; 2018 Mar; 43(4):700-707. PubMed ID: 28240291
[TBL] [Abstract][Full Text] [Related]
40. The effect of in vivo treatment with (-) delta 1-tetrahydrocannabinol, and other psychoactive drugs on the in vitro uptake of biogenic amines.
Hershkowitz M
Adv Biosci; 1978 Jul 22-23; 22-23():351-8. PubMed ID: 756835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
